Digital Trends & Insights, January 2026: A pharmaphorum industry rep... Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.